COMPOSITIONS AND METHODS FOR TREATING CANCER

IL3Rα antibody conjugates and uses thereof

Combination therapy of immunotoxin and checkpoint inhibitor

SUPPRESSION OF ITCH

CELL-TARGETING MOLECULES COMPRISING AMINO-TERMINUS PROXIMAL OR AMINO-TERMINAL, SHIGA TOXIN A SUBUNIT EFFECTOR REGIONS

Antimicrobial compositions comprising single domain antibodies and exotoxin

Targeted mosquitocidal toxins

Deimmunized therapeutic compositions and methods

Vaccine antigen with increased immunogenicity

Method for preparing bacterial polysaccharide-modified recombinant fusion protein and use of the protein

CYTOTOXIC PROTEINS COMPRISING CELL-TARGETING BINDING REGIONS AND SHIGA TOXIN A SUBUNIT REGIONS FOR SELECTIVE KILLING OF SPECIFIC CELL TYPES

De-Immunized, Shiga Toxin A Subunit Scaffolds and Cell-Targeting Molecules Comprising the Same

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

Compositions and methods for treatment of pain

Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers

Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers

EPHA3 and multi-valent targeting of tumors

Compositions and methods for treatment of pain

CELL-TARGETING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES

Tetanus toxoid and CCL3 improve DC vaccines

Antibodies to endoplasmin and their use

Adeno-associated viruses engineered for selectable tropism

Mutant lysenin pores

Serine protease molecules and therapies

TOXIC PEPTIDE PRODUCTION, PEPTIDE EXPRESSION IN PLANTS AND COMBINATIONS OF CYSTEINE RICH PEPTIDES

Human monoclonal antibodies specific for glypican-3 and use thereof

Sensor systems for target ligands and uses thereof

Methods of treatment for EpCAM positive bladder cancer

HER3 antigen binding proteins binding to the beta-hairpin of HER3

Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

Multivalent CD20-binding molecules comprising Shiga toxin A subunit effector regions and enriched compositions thereof

Amatoxin-antibody conjugates

ADMINISTRATION OF PLANT EXPRESSED ORAL TOLERANCE AGENTS

Methods and compositions based on diphtheria toxin-interleukin-3 conjugates

Circovirus sequences associated with piglet weight loss disease (PWD)

MOLECULAR SENSORS

METHODS AND COMPOSITIONS TO ENHANCE ACTIVITY OF CRY ENDOTOXINS

AN IMMUNOTOXIN FOR USE IN THE TREATMENT OF LEISHMANIASIS

exotoxin A with less immunogenic T cell and/or B cell epitopes

Anti-TIM-3 antibodies and methods of use thereof

Nucleotide sequences, vectors and host cells

Methods for the depletion of CD117+ cells

Anti-B7-H3 antibodies and antibody drug conjugates

High-throughput screening of functional antibody fragments, immunoconjugate comprising the same, and adaptor-drug conjugate for screening

Combination therapy of T cell activating bispecific antigen binding molecules and PD-1 axis binding antagonists

Compositions comprising polypeptides having xylanase activity and polypeptides having arabinofuranosidase activity

FUSION PROTEINS AND METHODS FOR TREATING, PREVENTING OR AMELIORATING PAIN

Diagnosis and treatment of cancer expressing ILT3 or ILT3 ligand

Method of treating a bladder cancer using a chimeric EGF-targeted bacterial toxin

Capping modules for designed ankyrin repeat proteins

Modified virus-like particles of CMV

COMPOSITIONS AND METHODS FOR TREATING CANCER

Modified Vip3 polypeptides

Anti-IL-23 antibodies, compositions, methods and uses

MODIFIED MICROBIAL TOXIN RECEPTOR FOR DELIVERING AGENTS INTO CELLS

Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo

Multivalent CD20-binding molecule comprising Shiga toxin A subunit effector polypeptides and enriched compositions thereof

Non-cleavable substance P conjugates and methods of use thereof

Cell-targeted cytotoxic constructs

Methods and compositions for enhancing the potency of superantigen mediated cancer immunotherapy

Dual purpose universal influenza vaccine confers protective immunity against anthrax

Nucleotide sequences, vectors and host cells

RECOMBINANT LISTERIA STRAIN EXPRESSING HETEROLOGOUS ANTIGEN FUSION PROTEINS AND METHODS OF USE THEREOF

Cell penetrating peptide, conjugate thereof with botulinum toxin, and use thereof

Single-chain variable fragment anti-CD133 antibodies and uses thereof

Isolated polypeptide of the toxin A and toxin B proteins of and uses thereof

Method for prophylaxis or treatment of erbb1 positive cancers using a variant peptidase d with reduced activity

CD7 nanobodies, encoding sequence and use thereof

Pseudomonas exotoxin A with less immunogenic B cell epitopes

METHOD FOR THE MANUFACTURING OF DI-CHAIN PROTEINS FOR USE IN HUMANS

Carrier immunoglobulins

Toxic peptide production, peptide expression in plants and combinations of cysteine rich peptides

IL3Rα antibody conjugates and uses thereof

Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo

Method for purifying active polypeptides or immunoconjugates

METHODS AND COMPOSITIONS FOR BI-SPECIFIC TARGETING OF CD19/CD22

Chimeric vaccine against fungal infections

Methods and compositions for modulating immune tolerance

Cellular vaccine and method of inducing an immune response in a subject

PHARMACEUTICAL COMPOSITION AGAINST CHRONIC BACTERIAL INFECTIONS

Cell-targeting molecules comprising protease-cleavage resistant, Shiga toxin A subunit effector polypeptides and carboxy-terminal moieties

RECOMBINANT POXVIRUS VECTOR COMPRISING TETANUS TOXIN FRAGMENT C

Chloroplast transit peptides

Antimicrobial agents

Chimeric protein toxins for expression by therapeutic bacteria

MODIFIED PSEUDOMONAS EXOTOXIN A

Dual specific immunotoxin for brain tumor therapy

Compositions comprising angiogenic factors and methods of use thereof

Recombinant vaccine strains and methods of producing the same

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

PRODUCTION OF CYTOTOXIC ANTIBODY-TOXIN FUSION IN EUKARYOTIC ALGAE

CHIMERIC POLYPEPTIDE COMPRISING THE FRAGMENT B OF SHIGA TOXIN AND PEPTIDES OF THERAPEUTIC INTEREST

Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof

Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof

Non-cytotoxic protein conjugates

Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers

Antigen chimera, antigen composition, vaccine, method of preparing the same and cassette thereof

Compositions and methods for delivery of bioencapsulated proteins across blood-brain and retinal barriers

Modified microbial toxin receptor for delivering agents into cells

Regulation of specific spinal neurons regulating pain transmission via chimeric toxins

Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof

MHC CLASS I EPITOPE DELIVERING POLYPEPTIDES AND CELL-TARGETED MOLECULES FOR DIRECT CELL KILLING AND IMMUNE STIMULATION VIA MHC CLASS I PRESENTATION AND METHODS REGARDING THE SAME

Vaccine compositions against porcine reproductive and respiratory syndrome and porcine circovirus associated diseases

DE-IMMUNIZED SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES FOR APPLICATIONS IN MAMMALS

Antimicrobial compositions comprising single domain antibodies and pseudomonas exotoxin

Biodegradable matrix comprising stem cells that express soluble TRAIL

Receptor targeting constructs and uses thereof

Tumor vascular marker-targeted vaccines

Oral delivery of angiotensin converting enzyme 2 (ACE2) or angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimental induced ocular disorders

Multiepitope fusion antigens and vaccines and their use in treatment of enterotoxigenic diarrhea

PESTICIDAL FUSION PROTEIN IMPROVEMENTS

Insecticidal proteins

INSECTICIDAL PROTEINS

EPHA3 And multi-valent targeting of tumors

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

Transduction buffer

Methods for using antibodies for 3′ iso-LM1 and 3′, 6′-iso-LD1tumor gangliosides

Tetanus toxoid and CCL3 improve DC vaccines

Designed repeat proteins binding to serum albumin

Anti-EPCAM antibodies and methods of use

Mesothelin domain-specific monoclonal antibodies and use thereof

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

Target-Specific Double-Mutant Fusion Protein and Preparation Process Therefor

Single-chain variable fragment anti-CD133 antibodies and uses thereof

Pseudomonas exotoxin a with less immunogenic T cell and/or B cell epitopes

OspA Fusion Protein for Vaccination against Lyme Disease

Human monoclonal antibodies specific for glypican-3 and use thereof

EPITOPE VACCINE FOR LOW IMMUNOGENIC PROTEIN AND PREPARING METHOD AND USAGE THEREOF

Compositions comprising angiogenic factors and methods of use thereof

Correlation of disease activity with clonal expansions of human papillomavirus 16-specific CD8+ T-cells in patients with severe erosive oral lichen planus

CELL-TARGETED MOLECULES COMPRISING AMINO-TERMINUS PROXIMAL OR AMINO-TERMINAL SHIGA TOXIN A SUBUNIT EFFECTOR REGIONS

IL-13 receptor binding peptides

Human monoclonal antibodies to O8E

ANTIBODIES WITH ULTRALONG COMPLEMENTARITY DETERMINING REGIONS

Coiled coil immunoglobulin fusion proteins and compositions thereof

Nucleotide sequences, vectors and host cells

Fusion protein to target and treat acute myeloid leukemia cells

Universal influenza vaccine

Botulinum neurotoxins with modified light chain specificity and methods for producing same

Cytolethal distending toxin subunit B conjugated or fused to toxin lethal factor

SUPPRESSION OF ITCH

GAS57 MUTANT ANTIGENS AND GAS57 ANTIBODIES

Chimeras of lumazine synthase and beta subunit of ABtoxins

Vaccines against pathogenic and methods of using the same

Capping modules for designed ankyrin repeat proteins

COMPOSITIONS AND METHODS FOR DETECTION AND TREATMENT OF HEPATOCELLULAR CARCINOMA

DIG-17 insecticidal cry toxins

MODIFIED MICROBIAL TOXIN RECEPTOR FOR DELIVERING AGENTS INTO CELLS

exotoxin A with less immunogenic B cell epitopes

Targeting peptides and uses thereof

Vaccine and therapeutic delivery system

Combination of immunotherapies with activators of Tie-2

Human Antibody Fragments Against Chondroitin Sulfate Proteoglycan 4 (CSPG4)

TARGETED ELIMINATION OF FACTOR VIII IMMUNE CELLS

Bivalent IL-2 fusion toxins

MOLECULAR CONJUGATES COMPRISING HUMAN MONOCLONAL ANTIBODIES TO DENDRITIC CELLS

Methods and compositions based on diphtheria toxin-interleukin-3 conjugates

CD20-binding immunotoxins for inducing cellular internalization and methods using same

COMPOSITION FOR TREATMENT AND DIAGNOSIS OF PANCREATIC CANCER

Immunogenic fusion polypeptides

ENDOLYSIN OBPGPLYS

Modified toxins

Method for screening mutant microorganism overproducing target metabolite using synthetic suicide genetic circuit

Method of introducing a toxin or dye into mammalian pluripotent cells using rBC2LCN

Treatment of metastatic tumors

Anti-Podoplanin Antibodies and Methods of Use

Vaccine for preventing porcine edema disease

Antibody recognizing folate receptors α and β

Methods of producing immunoconjugates

Anti-IL-23 antibodies

Immunoproteases

CHIMERA COMPRISING BACTERIAL CYTOTOXIN AND METHODS OF USING THE SAME

Human anti-human epidermal growth factor receptor antibody and encoding gene and application thereof

Method for delivering agents into cells using bacterial toxins

gene with coleopteran activity

CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same

Mesothelin domain-specific monoclonal antibodies and use thereof

Specific delivery of toxins conjugated with antibodies to activate matripase

Methods and compositions to enhance activity of Cry endotoxins

Programmable drug delivery profiles of tumor-targeted bacteria

Methods of Treating Pediatric Acute Lymphoblastic Leukemia with an Anti-CD22 Immunotoxin

Cellular vaccine and method of inducing an immune response in a subject

FUSION PROTEINS AND METHODS FOR TREATING, PREVENTING OR AMELIORATIONG PAIN

Circovirus sequences associated with piglet weight loss disease (PWD)

Circovirus sequences associated with piglet weight loss disease (PWD)

Engineered botulinum neurotoxin

αO-superfamily conotoxin peptide, pharmaceutical composition and use thereof

Toxic peptide production, peptide expression in plants and combinations of cysteine rich peptides

Vaccine and uses thereof

Highly immunogenic peptides derived from the human immunodeficiency virus V2 region

COMPOSITIONS AND METHODS FOR TREATING CANCER

Recombinant cytotoxic T-lymphocyte-associated protein 4 (CTLA4)

IgE CH3 peptide vaccine

Protein constructs designed for targeting and lysis of cells

COMPOSITION

COMPOSITIONS

Compositions comprising angiogenic factors and methods of use thereof

ANTITUMOR PROTOCOL

Mutant lysenin pores

Isolated polypeptide of the toxin A and toxin B proteins of and uses thereof

P97 fragments with transfer activity

Correlation of disease activity with clonal expansions of human papillomavirus 16-specific CD8+ T-cells in patients with severe erosive oral lichen planus

Carrier immunoglobulins

Carrier immunoglobulins

MODIFIED MICROBIAL TOXIN RECEPTOR FOR DELIVERING AGENTS INTO CELLS

ANTICANCER FUSION PROTEIN

Combination therapy with anti-CD74 and anti-CD20 antibodies provides enhanced toxicity to B-cell diseases

Orally administered plastid expressed cholera toxin B subunit-exendin 4 as treatment for type 2 diabetes

Endolysin OBPgpLYS

Cytotoxins comprising modified bouganin toxin for the treatment of cancer

Serine protease molecules and therapies

Porcine circovirus type-2 (PCV2) subunit vaccine

Methods and compositions for modulating immune tolerance

Dual delivery system for heterologous antigens

Dual specific immunotoxin for brain tumor therapy

Serine protease molecules and therapies

In vivo unnatural amino acid expression in the methylotrophic yeast

Suppression of cancer

Lytic domain fusion constructs and methods of making and using same

Regulation of specific spinal neurons regulating pain transmission via chimeric toxins

A1 moiety of cholera toxin A subunit as an adjuvant for mucosal and systemic vaccines

Anti-human XCR1 antibodies

HER3 antibodies binding to the beta-hairpin of HER3

Generation of anti-FN14 monoclonal antibodies by ex-vivo accelerated antibody evolution

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

Recombinant immunotoxin targeting mesothelin

Serine protease molecules and therapies

Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof

Human monoclonal antibodies to O8E

Anti-IL-23 Antibodies

Vaccines for suppressing IgE-mediated allergic disease and methods for using the same

HERV-K antigens, antibodies, and methods

Biotherapy for pain

Recombinant pokeweed antiviral proteins, compositions and methods related thereto

exotoxin A with less immunogenic T cell and/or B cell epitopes

Insecticidal proteins

Treatment and bioluminescent visualization using multimodal TRAIL molecules

FUSION PROTEINS

Anti-IL-23 antibodies, compositions, methods and uses

Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumors

Antibody for 3′-isoLM1 and 3′,6′-iso-LD1 gangliosides

B7-1-PE40KDEL exotoxin fusion gene-based DNA vaccine and the use thereof

Method for delivering agents into cells using bacterial toxins

Methods and compositions based on diphtheria toxin-interleukin-3 conjugates

Use of an anti-Tau pS422 antibody for the treatment of brain diseases

MIR-21 promoter driven targeted cancer therapy

Capping modules for designed ankyrin repeat proteins

Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases

Protein delivery system to generate induced pluripotent stem (iPS) cells or tissue-specific cells

Selective anticancer chimeric peptides which bind neuropilin receptor

Designed repeat proteins binding to serum albumin

Single chain variable fragment anti-CD133 antibodies and uses thereof

Method for purifying active polypeptides or immunoconjugates

Compositions and methods for the treatment of tumor of hematopoietic origin

Light-activated fusion proteins and uses therefor

THERAPEUTIC IMMUNIZATION IN HIV INFECTED SUBJECTS TO AUGMENT ANTIRETROVIRAL TREATMENT

Peptides mimicking HIV-1 viral epitopes in the V2 loop for the GP120 surface envelope glycoprotein

Chloroplasts engineered to express pharmaceutical proteins

P97 fragments with transfer activity

Treatment of metastatic tumors

Antibodies Against A Cancer-Associated Epitope of Variant HNRNPG and Uses Thereof

Dual Specific Immunotoxin for Brain Tumor Therapy

Administration of plant expressed oral tolerance agents

IL-17 binding compounds and medical uses thereof

Nucleic acids encoding GAS57 mutant antigens

Modified INSM1-promoter for neuroendocrine tumor therapy and diagnostics

Anti-IL-23 antibodies

Generation of anti-FN14 monoclonal antibodies by ex-vivo accelerated antibody evolution

Cytokine zalpha11 ligand

Non-cytotoxic protein conjugates

Carrier immunoglobulins

Endolysin OBPgpLYS

IL3Rα antibody conjugates and uses thereof

Modified Clostridial toxins with enhanced targeting capabilities for endogenous Clostridial toxin receptor systems

Methods of Treating Pediatric Acute Lymphoblastic Leukemia with an Anti-CD22 Immunotoxin

Serum resistance factors of gram positive bacteria

Compositions and methods for treatment of cancer

Monoclonal antibodies to dendritic cells

CONSTRUCTS FOR DELIVERY OF THERAPEUTIC AGENTS TO NEURONAL CELLS

Methods and compositions for bi-specific targeting of CD19/CD22

SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3

Compositions comprising angiogenic factors and methods of use thereof

METHOD FOR ENHANCING EXPRESSION OF RECOMBINANT PROTEIN

VECTOR FOR TREATING ALZHEIMER'S DISEASE

Recombinant fusion protein and polynucleotide construct for immunotoxin production

MIR-21 promoter driven targeted cancer therapy

Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells

Antibody fusion-mediated plant resistance against Oomycota

Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells

Tumor vascular marker-targeted vaccines

Circovirus sequences associated with piglet weight loss disease (PWD)

Chimera comprising bacterial cytotoxin and methods of using the same

Antibodies to endoplasmin and their use

Circovirus sequences associated with piglet weight loss disease (PWD)

Recombinant fusion protein and polynucleotide construct for immunotoxin production

Selective anticancer chimeric peptide comprising an EGF receptor-binding peptide and a cytotoxic peptide

METHODS FOR GENERATING ANTI-IL-23 ANTIBODIES, COMPOSITIONS, METHODS AND USES

Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis